It has inked a MoU with the Royal Society of Chemistry to accelerate the discovery of therapies for diseases like TB and malaria
New Delhi: The Council of Scientific and Industrial Research (CSIR) and the Royal Society of Chemistry (RSC) have signed a memorandum of understanding (MoU) to accelerate the discovery of novel therapies for neglected diseases.
Royal Society of Chemistry (RSC) is the largest European organisation for advancing chemical sciences.
The MoU, spanning three years, aims to address the objective of finding novel, faster-acting, and more effective regimens for TB and malaria by advancing the discipline of Cheminformatics.
The collaboration envisions conducting workshops and conferences to build links between experts and leaders in the coming years and will focus on jointly building an online repository of real and virtual molecular structures along with developing free-to -use software tools for drug discovery and development.
The partnership also aims at exploring the possibility of advancing OSDD’s e-learning program for students.
“Finding new drugs for TB is a major challenge. We are joining hands to find New Chemical Entities which could be potential anti-TB drugs,” CSIR Director General Samir K Brahmachari said.
The RSC’s Immediate Past President, David Phillips, who is in India to announce the MoU said, “Through this agreement, the CSIR and RSC are responding to the challenge of ‘lost data’ – that is the 90 per cent of research output that never gets published.